Daniel K. Saha

This study tests adaptive therapy protocols using gemcitabine and capecitabine on a mouse model of endocrine-resistant breast cancer, finding improved survival with adaptive strategies over high-dose combination therapy.

This paper investigates adaptive therapy with single cytotoxic or cytostatic drugs, finding it effective under specific conditions and dosing strategies.

This paper evaluates adaptive therapy strategies using two cytotoxic or two cytostatic drugs, finding that dose modulation protocols perform better with cytotoxic drugs while ping-pong protocols are more effective with cytostatic drugs under specific conditions.